|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08156 SINOPHARM TECH
Nominal 
0.300 +0.010 (+3.448%) | 2024/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 18,898 | 0.287% | 18,844 | 15,025 | 11,730 | 55,200 |
| Cost of Sales | (12,398) | -21.147% | (15,723) | (11,986) | (9,137) | (35,648) |
| Gross Profit | 6,500 | 108.267% | 3,121 | 3,039 | 2,593 | 19,552 |
| 2024/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (531) | 3,247 | 3,881 | |
| Profit / (Loss) before Taxation | (4,458) | 99.107% | (2,239) | 15,769 | (13,377) | (14,627) | |
| Taxation | 10 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (1,065) | 67.190% | (637) | (361) | (126) | 487 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (5,513) | 91.690% | (2,876) | 15,408 | (13,503) | (14,140) | |
| 2024/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | 3,380 | 80.267% | 1,875 | 4,001 | 9,068 | 10,015 |
| Depreciation & Amortisation | 363 | 51.250% | 240 | 692 | 668 | 1,598 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/12 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/12 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -2.170 | 38.217% | -1.570 | 8.460 | -7.500 | -8.250 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | (0.022) | -- | (0.960) | (0.815) | (0.665218) | (0.493371) |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -867 |
| %Change | -95.599% |
| EPS / (LPS) | HKD -0.002 |
| NBV Per Share ($) | HKD -0.058 |